Di Palma, M. (2022) “Managment of Relapsed/Refractory ALL With Inotuzumab During COVID-19. A Casr Report”, Mediterranean Journal of Hematology and Infectious Diseases, 14(1), p. e2022043. doi: 10.4084/MJHID.2022.043.